Reactions of nitrilimines with alkenes
Russ.Chem.Bull., Int.Ed., Vol. 60, No. 8, August, 2011
1683
(CDCl3), δ: 18.1 (ZꢀMe); 21.6, 25.3 (Me2C(5)); 26.1 (EꢀMe);
51.9 (CO2Me); 54.4 (C(4)); 55.5 (OMe); 73.1 (C(5)); 114.0 (Cm);
118.6 (=CH); 124.5 (Co); 135.7 (Cipso); 136.1 (=C); 141.4 (C(3));
157.3 (Cp); 163.4 (COO).
(Me); 26.1 (EꢀMe); 47.3 (C(3)); 51.6 (CO2Me); 110.8 (=CH2);
3
2
114.7 (Co, JC,F = 7.7 Hz); 115.9 (Cm, JC,F = 23.2 Hz); 124.3
(C(4)); 129.1, 132.6 (C(2´), C(5)); 140.2 (Cipso, 4JC,F = 2.3 Hz);
146.9 (C(2)); 158.3 (Cp, 1JC,F = 240 Hz); 164.2 (COO). 19F NMR
(CDCl3), δ: –123.3 (tt, CF, 3JH,F = 8.7 Hz, 4JH,F = 4.2 Hz).
Reaction of compound 1a with 2,3ꢀdimethylbutꢀ2ꢀene (6). The
products obtained from dihydroindazole 1a (316 mg) and tetꢀ
ramethylethene (6) (0.42 g) were separated by column chromatoꢀ
graphy on SiO2 (CHCl3—EtOAc, 5 : 1). They include methyl
1ꢀ(4ꢀmethoxyphenyl)ꢀ4,4,5,5ꢀtetramethylꢀ4,5ꢀdihydroꢀ1Hꢀpyrꢀ
azoleꢀ3ꢀcarboxylate (16a) (13 mg, 9%), methyl 2ꢀ[(4ꢀmethꢀ
oxyphenyl)hydrazono]ꢀ3,3,4ꢀtrimethylpentꢀ4ꢀenoate (17a) (14 mg,
10%), methyl 5ꢀ(2ꢀhydroxypropꢀ2ꢀyl)ꢀ1ꢀ(4ꢀmethoxyphenyl)ꢀ5ꢀ
methylꢀ4,5ꢀdihydroꢀ1Hꢀpyrazoleꢀ3ꢀcarboxylate (18a) (30 mg,
20%), and methyl 5ꢀacetylꢀ1ꢀ(4ꢀmethoxyphenyl)ꢀ5ꢀmethylꢀ4,5ꢀ
dihydroꢀ1Hꢀpyrazoleꢀ3ꢀcarboxylate (19a) (30 mg, 21%).
Compound 16a, colorless oil. HRMS (ESI): [M + Na]+,
calculated for C16H22N2O3Na 313.1523, found: 313.1523. MS
(EI), m/z (Irel (%)): 290 [M]+ (85), 275 [M – Me]+ (100), 259
[M – OMe]+ (10), 231 [M – COOMe]+ (22), 216 (22), 163 (40),
148 (74), 121 (20), 92 (20). IR, ν/cm–1: 2976, 2958, 1696 (C=O),
1508 (C=N), 1436. 1H NMR (CDCl3), δ: 1.10 (s, 6 H, Me2C(4));
1.23 (s, 6 H, Me2C(5)); 3.80, 3.84 (both s, 3 H each, 2 OMe);
Compound 15a, colorless oil. HRMS (ESI): [M + H]+,
calculated for C18H25N2O3 317.1860, found: 317.1856. 1H NMR
(CDCl3), δ: 1.69, 1.77 (both d, 3 H each, 2 Me at C(5), 4J = 1.5
Hz); 1.75 (t, 3 H, Me, 4J = 1.3 Hz); 3.78, 3.79 (both s, 3 H each,
3
2 OMe); 4.29 (br.d, 1 H, H(3), J = 9.5 Hz); 4.77 (m, 2 H,
3
4
=CH2); 5.51 (dsp, 1 H, H(4), J = 9.5 Hz, J = 1.5 Hz); 6.87
3
3
(d, 2 H, Hm, J = 9.0 Hz); 7.12 (d, 2 H, Ho, J = 9.0 Hz); 12.1
(br.s, 1 H, NH). 13C NMR (CDCl3), δ: 18.1 (ZꢀMe); 21.4 (Me);
26.1 (EꢀMe); 47.3 (C(3)); 51.4 (CO2Me); 55.7 (OMe); 110.6
(=CH2); 114.8, 115.0 (Co, Cm); 124.6 (C(4)); 127.9, 132.3 (C(2´),
C(5)); 137.8 (Cipso); 147.1 (C(2)); 155.1 (Cp); 164.3 (COO).
Methyl 1ꢀ(4ꢀfluorophenyl)ꢀ4,4ꢀdimethylꢀ5ꢀ(2ꢀmethylpropꢀ1ꢀ
enyl)ꢀ (13b) and methyl 1ꢀ(4ꢀfluorophenyl)ꢀ5,5ꢀdimethylꢀ4ꢀ(2ꢀ
methylpropꢀ1ꢀenyl)ꢀ4,5ꢀdihydroꢀ1Hꢀpyrazoleꢀ3ꢀcarboxylates
(14b) and methyl 2ꢀ[(4ꢀfluorophenyl)hydrazono]ꢀ5ꢀmethylꢀ3ꢀ
(propꢀ1ꢀenꢀ2ꢀyl)hexꢀ4ꢀenoate (15b). A reaction of dihydroindꢀ
azole 1b (0.31 g) with 2,5ꢀdimethylhexaꢀ2,4ꢀdiene (5) (0.55 g)
gave regioisomeric pyrazolines 13b and 14b (71 mg, 47%) in
a ratio of 5.7 : 1 (1H NMR) and hydrazone 15b (28 mg, 18%).
For the mixture of isomers 13b and 14b, found (%): C, 66.68;
H, 7.10; N, 8.72. C17H21FN2O2. Calculated (%): C, 67.09;
H, 6.95; N, 9.20.
3
3
6.85 (d, 2 H, Hm, J = 9.0 Hz); 7.17 (d, 2 H, Ho, J = 9.0 Hz).
13C NMR (CDCl3), δ: 19.5, 19.8 (Me2C(4), C(5)); 50.6 (C(4));
51.7 (CO2Me); 55.5 (OMe); 74.9 (C(5)); 113.9 (Cm); 125.5 (Co);
135.9 (Cipso); 145.4 (C(3)); 157.6 (Cp); 163.4 (COO).
Compound 13b. GCꢀMS (EI), m/z (Irel (%)): 304 [M]+ (46),
289 [M – Me]+ (100), 273 [M – OMe]+ (4), 257 (5), 245 (5),
229 (5), 177 (24), 176 (28), 162 (16), 161 (8), 136 (8), 122 (8),
110 (16), 109 (20), 95 (40). 1H NMR (CDCl3), δ: 1.23, 1.39 (both s,
3 H each, 2 Me at C(4)); 1.78, 1.80 (both d, 3 H each, =CMe2,
4J = 1.4 Hz); 3.85 (s, 3 H, OMe); 4.54 (d, 1 H, H(5), 3J = 9.8 Hz);
5.07 (dsp, 1 H, =CH, 3J = 9.8 Hz, 4J = 1.4 Hz); 6.92, 7.11 (both m,
2 H each, Ho, Hm). 13C NMR (CDCl3), δ: 18.4, 25.9 (=CMe2);
20.1, 26.0 (2 Me at C(4)); 50.0 (C(4)); 51.7 (CO2Me); 71.8
(C(5)); 115.4 (d, Cm, 2JC,F = 22.5 Hz); 117.1 (d, Co, 3JC,F = 8.0 Hz);
120.3 (=CH); 137.9 (=C); 139.8 (d, Cipso, 4JC,F = 2.4 Hz); 145.5
(C(3)); 158.3 (d, Cp, 1JC,F = 241 Hz); 162.8 (COO).
Compound 17a (~95% purity), oil. MS (EI), m/z (Irel (%)):
290 [M]+ (80), 275 [M – Me]+ (25), 259 [M – OMe]+ (5), 231
[M – COOMe]+ (10), 215 (10), 149 (12), 135 (20), 121 (100),
108 (35), 95 (50), 84 (90). IR, ν/cm–1: 3268 (NH), 3020, 1702
(C=O), 1670, 1542, 1518, 1438. 1H NMR (CDCl3), δ: 1.37 (s, 6 H,
4
Me2C(3)); 1.67 (t, 3 H, Me, J = 1.2 Hz); 3.72, 3.78 (both s,
3 H each, 2 OMe); 4.75 (q, 2 H, =CH2, 4J = 1.2 Hz); 6.87
(d, 2 H, Hm, 3J = 9.1 Hz); 7.13 (d, 2 H, Ho, 3J = 9.1 Hz); 12.0 (NH).
13C NMR (CDCl3), δ: 20.3 (Me); 27.2 (Me2C(3)); 45.2 (C(3));
50.8 (CO2Me); 55.7 (OMe); 108.4 (=CH2); 114.7, 114.8 (Co, Cm);
132.3 (C(4)); 138.1 (Cipso); 152.1 (C(2)); 154.9 (Cp); 164.5 (COO).
Compound 18a, yellowish oil. Found (%): C, 62.52; H, 7.33;
N, 8.67. C16H22N2O4. Calculated (%): C, 62.73; H, 7.24;
N, 9.14. MS (EI), m/z (Irel (%)): 306 [M]+ (5), 275 [M – OMe]+
(3), 247 [M – COOMe]+ (50), 215 (100); 203 (8); 188 (15), 148
(50), 132 (12); 121 (15); 107 (20); 92 (40); 84 (40); 77 (65); 59
(100). IR, ν/cm–1: 3608 (OH), 2980, 2958, 1696 (C=O), 1508
(C=N), 1449. 1H NMR (CDCl3), δ: 1.21, 1.25 (both s, 3 H each,
2 Me); 1.45 (s, 3 H, MeC(5)); 1.76 (br.s, 1 H, OH); 2.90, 3.25
Compound 14b. GCꢀMS (EI), m/z (Irel (%)): 304 [M]+ (34),
289 [M – Me]+ (16), 273 [M – OMe]+ (4), 257 (5), 248 (4), 245
[M – COOMe]+ (5), 229 (5), 152 (34), 151 (86), 136 (100), 110
(16), 109 (18), 95 (50). 1H NMR (CDCl3), δ: 1.24, 1.27 (both s,
3 H each, Me2C(4)); 1.76, 1.79 (both d, 3 H each, =CMe2,
4J = 1.4 Hz); 3.83 (s, 3 H, OMe); 3.84 (d, 1 H, H(5), 3J = 10.0 Hz);
3
4
5.09 (dsp, 1 H, =CH, J = 10.0 Hz, J = 1.4 Hz); 6.97, 7.20
(both m, 2 H each, Ho, Hm). 13C NMR (CDCl3), δ: 18.1, 26.1
(=CMe2); 21.7, 25.3 (Me2C(4)); 51.8 (CO2Me); 54.8 (C(4)); 72.8
(C(5)); 115.9 (d, Co, 3JC,F = 8.0 Hz); 116.2 (d, Cm, 2JC,F = 22.4 Hz);
118.2 (=CH); 136.4 (=C); 138.8 (d, Cipso, 4JC,F = 2.4 Hz); 142.2
(C(3)); 160.1 (d, Cp, 1JC,F = 243 Hz); 163.3 (COO).
2
(both d, H2C(4), J = 18.0 Hz); 3.76, 3.81 (both s, 3 H each,
2 OMe); 6.81 (d, 2 H, Hm, 3J = 9.0 Hz); 7.32 (d, 2 H, Ho,
3J = 9.0 Hz). 13C NMR (CDCl3), δ: 21.5 (MeC(5)); 25.6, 25.7
(2 Me); 43.6 (C(4)); 51.9 (CO2Me); 55.3 (OMe); 75.5 (C(5));
78.4 (C—OH); 113.7 (Cm); 125.8 (Co); 136.8, 136.9 (C(3), Cipso);
157.3 (Cp); 163.3 (COO).
Compound 15b, colorless crystals, m.p. 46—47 °C (CHCl3).
Found (%): C, 66.95; H, 6.86; N, 9.27. C17H21FN2O2. Calculatꢀ
ed (%): C, 67.09; H, 6.95; N, 9.20. MS (EI), m/z (Irel (%)): 304
[M]+ (38), 289 [M – Me]+ (10), 257 (10), 162 (20), 134 (32), 110
(100), 95 (40), 83 (65). IR, ν/cm–1: 3260 (NH), 2972, 2916,
1676 (C=O), 1612, 1544, 1516 (C=N), 1436. 1H NMR (CDCl3),
Compound 19a, colorless crystals, m.p. 101—102 °C (CHCl3).
Found (%): C, 62.12; H, 6.60; N, 9.38. C15H18N2O4. Calculatꢀ
ed (%): C, 62.06; H, 6.25; N, 9.65. MS (EI), m/z (Irel (%)): 290
[M]+ (14), 247 [M – Ac]+ (65), 215 (100), 188 (20), 160 (10),
148 (32), 107 (12), 92 (22), 77 (30). IR, ν/cm–1: 1716 (COO),
4
δ: 1.70, 1.78 (both d, 3 H each, Me2C(5), J = 1.5 Hz); 1.75
4
1
(t, 3 H, Me, J = 1.2 Hz); 3.79 (s, 3 H, OMe); 4.30 (br.d, 1 H,
1700 (C=O), 1652, 1616, 1540, 1508 (C=N), 1464. H NMR
H(3), 3J = 9.6 Hz); 4.78 (m, 2 H, =CH2); 5.48 (dsp, 1 H, H(4),
3J = 9.6 Hz, 4J = 1.5 Hz); 6.99 (m, 2 H, Hm); 7.11 (m, 2 H, Ho);
12.1 (br.s, 1 H, NH). 13C NMR (CDCl3), δ: 18.1 (ZꢀMe); 21.5
(CDCl3), δ: 1.48 (s, 3 H, MeC(5)); 2.23 (s, 3 H, Me); 3.09, 3.35
(both d, H2C(4), 2J = 17.9 Hz); 3.77, 3.90 (both s, 3 H each, 2 OMe);
3
3
6.81 (d, 2 H, Hm, J = 9.0 Hz); 6.99 (d, 2 H, Ho, J = 9.0 Hz).